ImmunoGen, Inc.
Edit Page
Report
Scan day: 12 February 2014 UTC
12
Virus safety - good
Description: Licenses tumor-activated prodrug technology, for development of small molecule anticancer agents, to optimise potency and toxicity. Manufacturing in Norwood, and headquarters in Cambridge, Massachusetts. (Nasdaq: IMGN)
ImmunoGen, Inc. develops targeted anticancer therapeutics. Our proprietary Targeted Antibody Payload (TAP) technology and strong antibody expertise form the basis for our development of our own products as well as of our partnerships with other companies.
Size: 255 chars
Contact Information
Email: —
Phone&Fax: —
Address: —
Extended: —
WEBSITE Info
| Page title: | ImmunoGen, Inc. |
| Keywords: | ImmunoGen, Inc. |
| Description: | ImmunoGen, Inc. |
| IP-address: | 64.158.242.20 |
WHOIS Info
| NS | Name Server: NS47.WORLDNIC.COM Name Server: NS48.WORLDNIC.COM |
| WHOIS | Status: clientTransferProhibited |
| Date | Creation Date: 04-apr-1997 Expiration Date: 05-apr-2018 |